The Company is a healthcare solution provider dedicated to the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The Company is primarily engaged in the industry of medical instrumental software with required medical instruments such software operates. Our main business during the reporting periods are sales of Particle Implantation Radiotherapy Treatment Planning System (FTTPS), sales of Medical Auxiliary Supplies, and others. The Company was established in 2022 and is headquartered in Beijing City, China.
Headquarters
Room 306, Net Building, Hong Jun Ying South Road, Chaoyang District
Beijing; Beijing;
Contact Details: Purchase the Pheton Holdings Ltd. (Beijing) (北京飞天兆业科技有限责任公司 (北京)) report to view the information.
Website: http://www.ftzy.com.cn
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service